Study Results For Unapproved Devices Could Be Heading To ClinicalTrials.gov
This article was originally published in The Gray Sheet
Executive Summary
Under an NIH proposed rule, trial results for products or indications that have yet to be approved or cleared would be subject to posting requirements, with certain allowances for delay. Also, trial registrations for unapproved devices, currently hidden from view, could sometimes see the light of day before FDA acts.
You may also be interested in...
ClinicalTrials.gov: NIH Busy Educating Sponsors On Mandates While Regs Remain In The Works
Draft rules are still being developed to fully implement ClinicalTrials.gov, but the law has been in effect for some time and officials say they are making a consistent effort to ensure study sponsors are educated on their new responsibilities.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.